Attached files
file | filename |
---|---|
EX-32.2 - EXHIBIT 32.2 - Sucampo Pharmaceuticals, Inc. | exh_322.htm |
EX-32.1 - EXHIBIT 32.1 - Sucampo Pharmaceuticals, Inc. | exh_321.htm |
EX-31.2 - EXHIBIT 31.2 - Sucampo Pharmaceuticals, Inc. | exh_312.htm |
EX-31.1 - EXHIBIT 31.1 - Sucampo Pharmaceuticals, Inc. | exh_311.htm |
EX-10.1 - EXHIBIT 10.1 - Sucampo Pharmaceuticals, Inc. | exh_101.htm |
10-Q - FORM 10-Q - Sucampo Pharmaceuticals, Inc. | f10q_110117p.htm |
Exhibit 12.1
Ratio of Earnings to Fixed Charges | ||||||||||||||||||||||||
Nine Months Ended September 30, | Year ended December 31, | |||||||||||||||||||||||
(in thousands, except for ratio) | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | ||||||||||||||||||
Pretax income from continuing operations | $ | (166,175 | ) | $ | 14,375 | $ | 43,675 | $ | 27,133 | $ | 10,943 | $ | 7,977 | |||||||||||
Fixed charges: | ||||||||||||||||||||||||
Interest expense | 8,762 | 23,761 | 6,854 | 1,520 | 1,894 | 2,346 | ||||||||||||||||||
Earnings (a) | (157,413 | ) | 38,136 | 50,529 | 28,653 | 12,837 | 10,323 | |||||||||||||||||
Fixed charges (b) | 8,762 | 23,761 | 6,854 | 1,520 | 1,894 | 2,346 | ||||||||||||||||||
Ratio of earnings to fixed charges (a/b) | 0 | 1.6 | 7.4 | 18.9 | 6.8 | 4.4 |